352 related articles for article (PubMed ID: 26922169)
1. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T
Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169
[TBL] [Abstract][Full Text] [Related]
2. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
3. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
[TBL] [Abstract][Full Text] [Related]
4. Clinically oriented three-step strategy for assessment of adnexal pathology.
Ameye L; Timmerman D; Valentin L; Paladini D; Zhang J; Van Holsbeke C; Lissoni AA; Savelli L; Veldman J; Testa AC; Amant F; Van Huffel S; Bourne T
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):582-91. PubMed ID: 22511559
[TBL] [Abstract][Full Text] [Related]
5. Multicentre external validation of IOTA prediction models and RMI by operators with varied training.
Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T
Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083
[TBL] [Abstract][Full Text] [Related]
6. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses.
Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D
Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221
[TBL] [Abstract][Full Text] [Related]
7. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
[TBL] [Abstract][Full Text] [Related]
8. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
[TBL] [Abstract][Full Text] [Related]
9. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
11. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
[TBL] [Abstract][Full Text] [Related]
13. The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.
Knafel A; Banas T; Nocun A; Wiechec M; Jach R; Ludwin A; Kabzinska-Turek M; Pietrus M; Pitynski K
Ultraschall Med; 2016 Oct; 37(5):516-523. PubMed ID: 26126150
[No Abstract] [Full Text] [Related]
14. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.
Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859
[TBL] [Abstract][Full Text] [Related]
15. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
[TBL] [Abstract][Full Text] [Related]
17. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
Davenport C; Rai N; Sharma P; Deeks JJ; Berhane S; Mallett S; Saha P; Champaneria R; Bayliss SE; Snell KI; Sundar S
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011964. PubMed ID: 35879201
[TBL] [Abstract][Full Text] [Related]
18. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
Tian C; Wen SB; Zhao CY; Yan XN; Du JX
BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
[TBL] [Abstract][Full Text] [Related]
19. Reliability of preoperative evaluation of postmenopausal ovarian tumors.
Niemi RJ; Saarelainen SK; Luukkaala TH; Mäenpää JU
J Ovarian Res; 2017 Mar; 10(1):15. PubMed ID: 28288666
[TBL] [Abstract][Full Text] [Related]
20. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis.
Nunes N; Ambler G; Foo X; Naftalin J; Widschwendter M; Jurkovic D
Ultrasound Obstet Gynecol; 2014 Nov; 44(5):503-14. PubMed ID: 24920435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]